Sinovac Biotech's Covid-19 Vaccine Gets Approval In Hong Kong For Children Over 6 Months Of Age

Sinovac Biotech Ltd. (SVA), a Chinese firm focused on infectious diseases, said on Wednesday that Hong Kong has approved its Covid-19 vaccine, CoronaVac, intended for kids aged 6 months to 3 years.

In phase III clinical studies, which evaluated CoronaVac among children aged 6 months to 17, preliminary results have shown that the vaccine has a good safety and immunogenicity profile, with no severe adverse reaction reported 6 months after two doses of vaccination among children aged 6 months to 35 months, according to the company.

CoronaVac has been authorized for emergency use for those above 3 years old in Hong Kong since February 15. As of August, CoronaVac has been approved for use in minors in 14 countries in Latin America, as well as in other countries in the regions of Asia and Africa.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Three experimental physicists - Alain Aspect, John F. Clauser and Anton Zeilinger - have won this year's Nobel Prize for physics for their achievements in quantum mechanics. Announcing the winners in Stockholm Tuesday, the Royal Swedish Academy of Sciences said the coveted prize was awarded to the trio "for experiments with entangled photons, establishing the violation of Bell inequalities and pi The United States has announced that it will be imposing new round of sanctions this week on perpetrators of violence against peaceful protestors in Iran. The United States is also holding accountable Iranian officials and entities such as the Morality Police, that are responsible for employing violence to suppress civil society, President Joe Biden said in a statement. Biden said he is gravel Factory Orders, Job Openings, and Labor Turnover Survey might be the major highlights on Tuesday. Fed speeches also will get attention. Early signs from the U.S. Futures Index suggest that Wall Street might open higher. Asian shares finished broadly up and European shares are progressing. As...
Follow RTT